medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2016, Number 2

<< Back Next >>

Salud Mental 2016; 39 (2)

Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico

Horigian VE, Espinal PS, Alonso E, Verdeja RE, Duan R, Usaga IM, Pérez-López A, Marín-Navarrete R, Feaster DJ

Language: English
References: 26
Page: 77-84
PDF size: 163.81 Kb.


ABSTRACT

Introduction Evidence shows a lag in adoption of evidence-based practices (EBPs) for substance abuse treatment and supports the need for studying the factors involved in this worldwide problem.
Objective This study aimed to assess the readiness and barriers to adopt EBPs for substance abuse in a sample of outpatient treatment centers of a newly created Mexican Clinical Trials Network.
Method An online survey was administered to directors (n = 8) and clinicians (n = 40) from seven outpatient treatment centers in Mexico. Questions were obtained from two surveys that had been implemented in the US to assess the same objectives.
Results Respondents reported being more ready to adopt Cognitive Behavioral Therapy (CBT, 83.3%) and Motivational Enhancement Therapy (MET, 79.1%), compared to 12 step facilitation (58.3%), couples therapy (56.2%), Brief Strategic Family Therapy (BSFT, 66.6%), and motivational incentives (60.4%). Directors had lower mean resistance to EBPs (11.8 vs. 17.4; p = 0.01) than clinicians. The biggest barriers identified by directors to EBP adoption were not having enough clinical staff, being unable to afford well-trained staff, not enough psychiatric and medical support.
Discussion and conclusion CBT and MET emerged as the most frequently used evidence based practices in the sites that are part of the Mexican Clinical Trials Network. Staff positive attitudes towards EBPs are critical for adoption.


REFERENCES

  1. Haug NA, Shopshire M, Tajima B, Gruber V et al. Adoption of evidence- based practices among substance abuse treatment providers. J Drug Education 2008;38(2):181-192. PMID: 18724657.

  2. Marinelli-Casey P, Domier C, Rawson, R. The gap between research and practice in substance abuse treatment. Psychiatric Services 2002;53(8):984-7. PMID: 12161673.

  3. McGovern MP, Fox TS, Xie H, Drake RE. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. J Substance Abuse Treatment 2004;26: 305-312. PMID: 15182895.

  4. McLellan A. Technology transfer in the treatment of addiction. J Substance Abuse Treatment 2002;22:169–70. PMID: 12072161.

  5. Knudsen HK, Roman PM. Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations. J Substance Abuse Treatment 2015;49:1-7. doi: 10.1016/j.jsat.2014.08.003.

  6. Amodeo M, Ellis MA, Samet JH. Introducing evidence-based practices into substance abuse treatment using organization development methods. American J Drug Alcohol Abuse 2006;32(4):555–560. doi:10.1080/00952990600920250.

  7. McCarty D, Fuller BE, Arfken C, Miller M et al. Direct care workers in the national drug abuse treatment clinical trials network: Characteristics, opinions, and beliefs. Psychiatric Services (Washington, D.C.) 2007;58(2):181–190. doi:10.1176/appi.ps.58.2.181.

  8. Squires D, Gumbley SJ, Storti SA. Training substance abuse treatment organizations to adopt evidence-based practices: the Addiction Technology Transfer Center of New England Science to Service Laboratory. J Substance Abuse Treatment 2008;34(3):293-301. PMID: 17600652.

  9. Tai B, Straus MM, Liu D, Sparenborg S et al. The first decade of the national drug abuse treatment clinical trials network: Bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment. 2010,38(Suppl 1): S4-13. doi: 10.1016/j.jsat.2010.01.011.

  10. Addiction Technology Transfer Center (ATTC), Network Technology Transfer Workgroup. Research to practice in addiction treatment: Key terms and a field-driven model of technology transfer. J Substance Abuse Treatment 2011;41(2): 169-178. http://dx.doi.org/10.1016/j. jsat.2011.02.006.

  11. Horigian VE, Marín-Navarrete RA, Verdeja RE, Alonso E et al. Technology transfer for the implementation of a clinical trials network on drug abuse and mental health treatment in Mexico. Pan-American Health Organization. (In press).

  12. Benjet C, Borges G, Medina-Mora ME, Fleiz C et al. Prevalence and socio demographic correlates of drug use among adolescents: results from the Mexican adolescent mental health survey. Addiction 2007;102:1261–1268. PMID: 17624976.

  13. Rojas E, Real T, García S, Medina-Mora ME. Revisión sistemática sobre tratamiento de adicciones en México. Salud Ment 2011;34:351-365.

  14. Ducharme LJ, Knudsen HK, Roman PM, Johnson JA. Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network. J Substance Abuse Treatment 2007;32(4): 321- 9. doi:10.1016/j.jsat.2006.05.021.

  15. Roman PM, Abraham AJ, Rothrauff TC, Knudsen HK. A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. J Substance Abuse Treatment 2010;38(Suppl 1):S44-S52. doi: 10.1016/j.jsat.2009.12.008.

  16. Lehman WE, Simpson DD, Knight DK, Flynn PM. Integration of treatment innovation planning and implementation: strategic process models and organizational challenges. Psychology Addictive Behaviors 2011;25(2):252-61. doi: 10.1037/a0022682.

  17. Lundgren L, Amodeo M, Chassler D, Krull I et al. Organizational readiness for change in community-based addiction treatment programs and adherence in implementing evidence-based practices: a national study. J Substance Abuse Treatment 2013;45(5):457-65. doi: 10.1016/j. jsat.2013.06.007.

  18. Lundgren L, Chassler D, Amodeo M, D’Ippolito M et al. Barriers to implementation of evidence-based addiction treatment: a national study. J Substance Abuse Treatment 2012;42(3):231-8. doi: 10.1016/j. jsat.2011.08.003.

  19. Glasner-Edwards S, Rawson R. Evidence-based practices in Aaddiction treatment: Review and recommendations for public policy. Health Policy 2010;97(2-3):93–104. doi:10.1016/j.healthpol.2010.05.013.

  20. Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Administration Policy Mental Health 2011;38(1):4–23. doi:10.1007/ s10488-010-0327-7.

  21. Simpson DD, Flynn PM. Moving innovations into treatment: A stagebased approach to program change. J Substance Abuse Treatment. 2007;33(2):111–120. doi:10.1016/j.jsat.2006.12.023.

  22. Fixsen DL, Blase KA, Naoom SF, Wallace F. Core implementation components. Research on social work practice. 2009;19:531–40. doi: 10.1177/1049731509335549.

  23. Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI. A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework. Health Research Policy Systems. 2015;13:16. doi:10.1186/s12961-015-0005-z.

  24. Aarons GA. Mental health provider attitudes toward adoption of evidence- based practice: The Evidence-Based Practice Attitude Scale (EBPAS). Mental Health Services Research 2014;6(2):61–74.

  25. Prochaska JO, DiClemente CC. Transtheoretical therapy: Toward a more integrative model of change. Psychotherapy Theory Research Practice 1982;19(3):276-288.

  26. Aarons GA, Sawitzky AC. Organizational Culture and Climate and Mental Health Provider Attitudes Toward Evidence-Based Practice. Psychological Services 2006;3(1):61–72. doi:10.1037/1541-1559.3.1.61.




2020     |     www.medigraphic.com